Marı́a Belén Jiménez-Dı́az

Author

Also Known As

Jimenez-Diaz, Maria Belen, M. Belén Jiménez-Díaz, MARÍA BELÉN JIMÉNEZ-DÍAZ, Mara Beln Jimnez-Daz, Maria Belen Jimenez-Diaz, Maria Belén Jiménez-Díaz, Mariá Belén Jiménez-Diaz, María Belén Jiménez-Díaz, María B. Jiménez-Díaz, María Belén Jiménez-Diaz

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Spain)Medicines for Malaria Venture Swiss Tropical and Public Health Institute University of Basel Monash University

About

Marı́a Belén Jiménez-Dı́az is an author at GlaxoSmithKline (Spain) specializing in medicine, malaria, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.4K
2	Biochemistry	10	10	510
3	Natural Sciences	9	9	452
4	Biomolecular Engineering	3	3	306
5	Health Sciences	1	1	24

Marı́a Belén Jiménez-Dı́az

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
A novel multiple-stage antimalarial agent that inhibits protein synthesis Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross, Nature Antiparasitic AgentMedicineMalariaPharmacologyProtein Synthesis	2015	452
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria Margaret A. Phillips, Julie Lotharius, Kennan C. Marsh, Science Translational Medicine	2015	367
Quinolone-3-Diarylethers: A New Class of Antimalarial Drug Aaron Nilsen, Alexis N. LaCrue, Karen L. White, Science Translational Medicine	2013	296
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent<i>Plasmodium falciparum</i>Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential José M. Coterón, María Marco, Jorge Esquivias, Journal of Medicinal Chemistry	2011	280
Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinase Tanya Paquet, Claire Le Manach, Diego González Cabrera, Science Translational Medicine	2017	262
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of <i>Plasmodium</i> Marı́a Belén Jiménez-Dı́az, Daniel Ebert, Yandira G. Salinas, Proceedings of the National Academy of Sciences Phenotypic ScreeningAntiparasitic AgentMalariaImmunologyMolecular Biology	2014	238
Improved Murine Model of Malaria Using<i>Plasmodium falciparum</i>Competent Strains and Non-Myelodepleted NOD-<i>scid IL2R</i>γ<sup><i>null</i></sup>Mice Engrafted with Human Erythrocytes Marı́a Belén Jiménez-Dı́az, Teresa Mulet, Sara Viera, Antimicrobial Agents and Chemotherapy Drug TargetLaboratory ImmunologyAntiparasitic AgentMalariaImmunology	2009	187
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes Íñigo Angulo‐Barturen, Marı́a Belén Jiménez-Dı́az, Teresa Mulet, PLoS ONE	2008	161
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria Christel Brunschwig, Nina Lawrence, Dale Taylor, Antimicrobial Agents and Chemotherapy	2018	136
Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model* Michael L. Booker, Cecilia M. Bastos, Martin Kramer, Journal of Biological Chemistry	2010	134

Page 1